Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.18
-0.0174-0.79%
Volume:75.28K
Turnover:160.72K
Market Cap:36.85M
PE:-1.03
High:2.25
Open:2.21
Low:2.03
Close:2.20
Loading ...

Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition

Dow Jones
·
28 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Advances Relationship With Anson Funds With $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt

THOMSON REUTERS
·
28 Jan

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9 Million Financing, Including Above the Market Equity and Senior Secured Debt

PR Newswire
·
28 Jan

NRX Pharmaceuticals, Inc. (Nasdaq: Nrxp) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

THOMSON REUTERS
·
21 Jan

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement

PR Newswire
·
21 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces the Appointment of Michael Taylor to Its Board of Directors and Appointment of Anita Nunes as Board Observer; MS. Nunes to Be Appointed Director of Hope Therapeutics, Inc.

THOMSON REUTERS
·
15 Jan

Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces the Appointment of Michael Taylor to its Board of Directors and Appointment of Anita Nunes as Board Observer; Ms. Nunes to be Appointed Director of HOPE Therapeutics, Inc.

Dow Jones
·
15 Jan

Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

Dow Jones
·
14 Jan

NRx Pharmaceuticals files to uplist securities to Nasdaq Global Market

TIPRANKS
·
13 Jan

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces It Has Filed an Application With Nasdaq to Uplist to the Nasdaq Global Market From the Nasdaq Capital Market

THOMSON REUTERS
·
13 Jan

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market

PR Newswire
·
13 Jan

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Conduct Investor Workshop at the Mar-A-Lago Club

PR Newswire
·
10 Jan

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Dr. Jonathan Javitt and Dr. David Feifel to Present Keynote Address, Beyond Ketamine Monotherapy: Combined Interventional Treatment of Suicidal Depression and PTSD, at the 8th Annual Neuroscience Innovation Forum in San Francisco

PR Newswire
·
07 Jan

NRx Pharmaceuticals' Acquisition Likely to Result in Multiple Avenues of Growth -- Market Talk

Dow Jones
·
07 Jan

BRIEF-Hope Therapeutics™, Inc. And Nrx Pharmaceuticals, Inc.Announce Signing Of Binding Term Sheet For $27 Million In Funding For Hope Clinic Acquisitions And Pharmaceutical Operations

Reuters
·
07 Jan

NRx Pharmaceuticals, HOPE sign term sheet for $27M in funding

TIPRANKS
·
06 Jan